Previous close | 13.57 |
Open | 13.88 |
Bid | 13.52 x 100 |
Ask | 13.61 x 200 |
Day's range | 13.45 - 14.00 |
52-week range | 9.14 - 14.00 |
Volume | |
Avg. volume | 124,590 |
Market cap | 603.76M |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | 35.74 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.32 (2.43%) |
Ex-dividend date | 10 Jul 2024 |
1y target est | N/A |
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
STERIS' (STE) AST successfully offers an extensive range of sterilization modalities through a worldwide network of more than 50 contract sterilization and laboratory facilities.
STERIS' (STE) Healthcare business and strong rebound prospects of the AST segment appear encouraging. However, macroeconomic concerns remain a challenge.